Acorda Therapeutics to present at upcoming conferences

American Pharmacy News Reports | Feb 7, 2017
Dr. Ron Cohen will speak at the Leerink Partners 6th Annual Global Healthcare Conference.
Dr. Ron Cohen will speak at the Leerink Partners 6th Annual Global Healthcare Conference. | Contributed photo
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. 
Dr. Ron Cohen, Acorda president and CEO, will speak at the Leerink Partners 6th Annual Global Healthcare Conference. The conference will be at 10:30 a.m. on Feb. 16, in New York, and will be available to live audio webcast at http://wsw.com/webcast/leerink28/acor.
Cohen will again present on behalf of the company at the RBC 2017 Healthcare Conference, also in New York. This event will be at 10 a.m. on Feb. 23. Just as the Leerink Partners conference, the RBC will be available for a live audio webcast at http://www.veracast.com/webcasts/rbc/healthcare2017/42205412441.cfm.
More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020